A new Research Letter suggests meningococcal group B vaccination (MBV) offers significant protection against gonorrhea, a sexually transmitted disease.
Most women infected with gonorrhea do not have any symptoms. Even when a woman has symptoms, they are often mild and can be mistaken for a bladder or vaginal infection.
Vaccination Significantly Protected College Students from Gonorrhea
Overestimation of Oxygen Saturation Leads to Delayed COVID-19 Treatment
Patients with unrecognized need for COVID-19 therapy appear to have higher odds of readmission, regardless of race
Mortality Risk Increased for Six Months After COVID-19 in Veterans
Those who survived COVID-19 had reduced mortality on days 181 to 365 and 366 to 730
Is One HPV Vaccine Dose Enough Cancer Protection?
When the World Health Organization (WHO) updated its recommendations for the human papillomavirus (HPV) vaccine in late 2022, it stated that a single-dose schedule could provide a comparable efficacy and durability of cancer protection compared to a two-dose regimen.
Since sexually transmitted HPV causes more than 95% of cervical cancer, many countries sought independent clinical research to support the WHO's revised recommendation.
No Change in Depression Seen in Children Across the Globe From 2004 to 2019
Findings based on 41 studies with data for children younger than 13 years old
Some Immunosuppressed Do Not Have Anti-Spike Antibodies After COVID-19 Vaccination
IgG anti-spike antibodies undetectable in ~20 percent with immunosuppression who had received three or more COVID-19 vaccines
Hospital COVID-19 Burden Impacted NSTEMI Treatment, Outcome
Outcomes and treatment worse for patients hospitalized during weeks with a high hospital COVID-19 burden
Three COVID-19 Technology Licensing Agreements Confirmed
The World Health Organization (WHO) today announced it signed new licensing agreements related to innovative vaccine technologies.
The COVID-19 Technology Access Pool (C-TAP) is a multi-stakeholder partnership that facilitates sharing of intellectual property, knowledge, and innovations.
On August 29, 2023, it announced that three new licensing agreements were acquired through the Medicines Patent Pool (MPP).
These agreements include the following licenses to transfer know-how, materials, and clinical data needed in different countries:
Pediatric ICU Admissions for SARS-CoV-2 Decreased Across Waves
However, no reduction seen in ventilatory support or oxygen therapy for those younger than 5 years
Malaria Health Alert Issued by the U.S. CDC
The Centers for Disease Control and Prevention (CDC) today announced Health Alert Network (HAN) Health Update (CDCHAN-00496) was issued to share new information about locally acquired malaria cases identified in the United States in 2023.
On August 18, 2023, a single case of locally acquired malaria was reported in Maryland in the National Capital Region.